Pompe Disease PBMC

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

5 lots match
5 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Pompe Disease PBMC 80186 151725 Female 46-60 Caucasian Cryopreserved 1 mL 4 10M Pombiliti + Opfolda 20mg/kg + 260mg, Q 2 weeks Pompe Disease United States 2026 — — — — — — — — — 219655; 219654; 219653; 219652PBMC10M cellsPompe DiseasePompe DiseaseNo30.78NoNoNoNoNoNOYesStoredIn Stock
$891
Pompe Disease PBMC 80185 151660 Female 46-60 Caucasian Cryopreserved 1 mL 6 10M Ventolin HFA 90 mcg per puff, 2 puffs 4 to 6 hours PRN, asthma, currently taking-; Buspar 10 mg TID, anxiety, currently taking-; Venlafaxine 50 mg TID, depression, currently taking-; Xanax 0.5mg Q8 PRN, anxiety, currently taking-; Norco 7.5mg/325mg Q6 PRN, pain, currently taking-; Ambien 10mg Q night, insomnia, currently taking-; Cyclobenzaprine 10 mg Q8 hours PRN, pain, currently taking-; Benadryl 50mg PRN, itching from narcotics, currently taking-; Nexviazyme 20mg/kg IV Q 2 weeks, Pompe, currently taking-(pre meds for infusions Singulair, Zyrtec, Solu-Medrol) Pompe Disease United States 2026 — — — — — — — — — 218923; 218924; 218922; 218921; 218920; 218919PBMC10M cellsPompe DiseasePompe DiseaseYesSeasonal24.59NoNoNoNo101YesNOYesStoredIn Stock
$891
Pompe Disease PBMC 80090 145398 Female 46-60 Caucasian Cryopreserved 1 mL 6 10M Synthroid 112mcg QD currently taking Sertraline 25mg QD ( used to be on 50mg decreased ), currently taking, Nexviazyme infusions 20mg/kg, ERT replacement, Q 2 weeks, next dose Pompe Disease United States 2026 — — — — — — — — — 217472; 217471; 217469; 217468; 217470; 217467PBMC10M cellsPompe DiseasePompe DiseaseYesGluten, Dairy19.97NoNoNoNoNoNOYesStoredIn Stock
$891
Pompe Disease PBMC 80033 150928 Male 18-30 Caucasian Cryopreserved 1 mL 2 10M Adderall 25 mg QD, ADHD, currently taking Adderall 10mg PRN, ADHD, currently taking ( only takes PRN 1-2x month) Nexviazyme infusion 20mg/kg, next dose will be on, infusions every 2 weeks Pompe Disease United States 2026 — — — — — — — — — 217095; 217094PBMC10M cellsPompe DiseasePompe DiseaseNo33.74NoNoNoNoNoYESYesStoredIn Stock
$891
Pompe Disease PBMC 73323 145344 Male 31-45 Caucasian Cryopreserved 1 mL 4 10M Nexviazyme 20mg/kg IV q 2 weeks, currently taking Vitiligo, Pompe Disease United States 2026 — — — — — — — — — 186063; 186064; 186065; 186066PBMC10M cellsPompe DiseasePompe Disease;VitiligoNo25.03NoNoNoNoNoNONoStoredIn Stock
$891

Showing 1–5 of 5 lots

About Pompe Disease PBMC

Pompe Disease PBMC are sourced from consented donors with documented Pompe disease. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Pompe Disease research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Pompe Disease
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Pompe Disease PBMC with normal donor samples for comparison

Healthy Donor PBMCs

733 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information